A New Reality: EMA Published First Guidance On New MDR/IVDR Rules For Certain Devices
Source: ICON Plc
The increasing pace of innovation and blurring boundaries between pharma and device products have led to new drug-device combination products and the need for updated regulatory guidances.
As a result, the European Medicines Agency’s (EMA’s) Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) and the European Commission published a Q&A document detailing information for products that need both the drug and the device components to function. This document is the first in a series of guidances to help manufacturers prepare for compliance under the new EU MDR and IVDR rules.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
ICON Plc
This website uses cookies to ensure you get the best experience on our website. Learn more